Bonfante L - Search Results

1

Nonenzymatically glycated lipoprotein ApoA-I in plasma of diabetic and nephropathic patients.

Lapolla A, Brioschi M, Banfi C, Tremoli E, Cosma C, Bonfante L, Cristoni S, Seraglia R, Traldi P. Lapolla A, et al. Among authors: bonfante l. Ann N Y Acad Sci. 2008 Apr;1126:295-9. doi: 10.1196/annals.1433.005. Epub 2007 Dec 13. Ann N Y Acad Sci. 2008. PMID: 18079481

2

Advanced glycation end products/peptides: an in vivo investigation.

Lapolla A, Fedele D, Reitano R, Bonfante L, Pastori G, Seraglia R, Tubaro M, Traldi P. Lapolla A, et al. Among authors: bonfante l. Ann N Y Acad Sci. 2005 Jun;1043:267-75. doi: 10.1196/annals.1333.032. Ann N Y Acad Sci. 2005. PMID: 16037247

3

On the search for glycated lipoprotein ApoA-I in the plasma of diabetic and nephropathic patients.

Lapolla A, Brioschi M, Banfi C, Tremoli E, Bonfante L, Cristoni S, Seraglia R, Traldi P. Lapolla A, et al. Among authors: bonfante l. J Mass Spectrom. 2008 Jan;43(1):74-81. doi: 10.1002/jms.1274. J Mass Spectrom. 2008. PMID: 17721906

4

Urinary peptides as a diagnostic tool for renal failure detected by matrix-assisted laser desorption/ionisation mass spectrometry: an evaluation of their clinical significance.

Lapolla A, Molin L, Seraglia R, Sechi A, Cosma C, Bonfante L, Chilelli NC, Ragazzi E, Traldi P. Lapolla A, et al. Among authors: bonfante l. Eur J Mass Spectrom (Chichester). 2011;17(3):245-53. doi: 10.1255/ejms.1124. Eur J Mass Spectrom (Chichester). 2011. PMID: 21828415

5

Effectiveness of a diet with low advanced glycation end products, in improving glycoxidation and lipid peroxidation: a long-term investigation in patients with chronic renal failure.

Chilelli NC, Cremasco D, Cosma C, Ragazzi E, Francini Pesenti F, Bonfante L, Lapolla A. Chilelli NC, et al. Among authors: bonfante l. Endocrine. 2016 Nov;54(2):552-555. doi: 10.1007/s12020-015-0805-5. Epub 2015 Nov 20. Endocrine. 2016. PMID: 26589418 Clinical Trial. No abstract available.

6

Mass spectrometric study of in vivo production of advanced glycation end-products/peptides.

Lapolla A, Fedele D, Reitano R, Bonfante L, Guizzo M, Seraglia R, Tubaro M, Traldi P. Lapolla A, et al. Among authors: bonfante l. J Mass Spectrom. 2005 Jul;40(7):969-72. doi: 10.1002/jms.842. J Mass Spectrom. 2005. PMID: 15768376 No abstract available.

7

Suspension of ACE-I and ARB treatment is associated with acute increase in serum AGE levels in patients on peritoneal dialysis.

Bonfante L, Virga G, Lapolla A, Toffolo K, Del Prete D, Scaparrotta G, Alessi M, D'Angelo A. Bonfante L, et al. Perit Dial Int. 2011 Jan-Feb;31(1):94-7. doi: 10.3747/pdi.2010.00015. Perit Dial Int. 2011. PMID: 21282389 No abstract available.

8

Peritoneal dialysis in diabetic patients.

Bertoli M, Bonfante L, Gambaro G, Cara M, Virgilio B, D'Angelo A. Bertoli M, et al. Among authors: bonfante l. Contrib Nephrol. 2001;(131):51-60. doi: 10.1159/000060060. Contrib Nephrol. 2001. PMID: 11125563 Review. No abstract available.

9

Parathyroid hormone and bone metabolism in kidney-transplanted patients.

D'Angelo A, Calò L, Giannini S, Carraro G, Bonfante L, Favaro S, Zaninotto M, Perin N, Di Landro D, Rigotti P, Antonello A. D'Angelo A, et al. Among authors: bonfante l. Clin Nephrol. 2000 Apr;53(4):suppl 19-22. Clin Nephrol. 2000. PMID: 10809430

10

Effect of doxazosin in mild to moderate hypertensive patients with insulin-dependent diabetes mellitus.

Calò L, Davis PA, Cantaro S, Bonfante L, Castrignano R, Carraro G, D'Angelo A. Calò L, et al. Among authors: bonfante l. Acta Diabetol. 1998 Jul;35(2):96-100. doi: 10.1007/s005920050111. Acta Diabetol. 1998. PMID: 9747962 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

76 results

Search Page